<a href='https://email.asam.org/t/t-i-gihitg-l-n/'>Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting</a> 
JAMA Network Open 
Injectable-only buprenorphine protocols are an exciting new strategy for buprenorphine initiation, particularly in the fentanyl era. This is a cohort study of 95 patients with moderate to severe opioid use disorder who received care in a low-threshold setting in Seattle. 79% of patients included in the study were experiencing homelessness or living in permanent supportive housing. Patients selected a long-acting injectable (LAI) buprenorphine initiation protocol which included three escalating doses of LAI buprenorphine over three days, with no sublingual buprenorphine and without cessation of fentanyl/opioid use. 75% of the patients completed the protocol, and 64% received a second monthly dose of LAI buprenorphine.
 
<a href='https://email.asam.org/t/t-e-gihitg-l-td/'>Read this issue of the ASAM Weekly</a>
<a href='https://email.asam.org/t/ViewEmail/t/409ED172E9728DA22540EF23F30FEDED?alternativeLink=True'>Subscribe to the ASAM Weekly</a>
<a href='https://email.asam.org/t/ViewEmail/t/7B8FCC540811FB9A2540EF23F30FEDED/C67FD2F38AC4859C/?tx=0&previewAll=1&print=1&source=PrintPreview&context=BE1559E32AC7F640D744A813E2B67A32'>Visit ASAM</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting

This Week in Addiction Medicine from ASAM

AI Chapters

AI Insights

Reviews